151 related articles for article (PubMed ID: 2056278)
21. HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination.
Danke NA; Kwok WW
J Immunol; 2003 Sep; 171(6):3163-9. PubMed ID: 12960344
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.
Skinner MA; Watson L; Geursen A; Tan PL
Ann Rheum Dis; 1994 Mar; 53(3):171-7. PubMed ID: 8154934
[TBL] [Abstract][Full Text] [Related]
23. Recognition by class II alloreactive T cells of processed determinants from human serum proteins.
Panina-Bordignon P; Corradin G; Roosnek E; Sette A; Lanzavecchia A
Science; 1991 Jun; 252(5012):1548-50. PubMed ID: 1710827
[TBL] [Abstract][Full Text] [Related]
24. Viral peptide specific induction of MHC class II expression by murine T cell clones.
Thomas DB; Smith CA; Graham CM
J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
[TBL] [Abstract][Full Text] [Related]
25. Preferential usage of the T-cell receptor by influenza virus hemagglutinin-specific human CD4+ T lymphocytes: in vitro life span of clonotypic T cells.
Prévost-Blondel A; Chassin D; Zeliszewski D; Dorval I; Sterkers G; Pannetier C; Guillet JG
J Virol; 1995 Dec; 69(12):8046-50. PubMed ID: 7494319
[TBL] [Abstract][Full Text] [Related]
26. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
27. Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice.
Gerhard W; Haberman AM; Scherle PA; Taylor AH; Palladino G; Caton AJ
J Virol; 1991 Jan; 65(1):364-72. PubMed ID: 1702160
[TBL] [Abstract][Full Text] [Related]
28. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
Pinet V; Malnati MS; Long EO
J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
[TBL] [Abstract][Full Text] [Related]
29. Human helper T-cell clones that recognize different influenza hemagglutinin determinants are restricted by different HLA-D region epitopes.
Eckels DD; Sell TW; Bronson SR; Johnson AH; Hartzman RJ; Lamb JR
Immunogenetics; 1984; 19(5):409-23. PubMed ID: 6202629
[TBL] [Abstract][Full Text] [Related]
30. The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen.
Thomas DB; Hodgson J; Riska PF; Graham CM
J Immunol; 1990 Apr; 144(7):2789-94. PubMed ID: 1690778
[TBL] [Abstract][Full Text] [Related]
31. Direct evaluation of antigen binding to human T lymphocyte clones: involvement of major histocompatibility complex products in antigen binding.
Zanders ED; Feldmann M; Green N; Lamb JR
Eur J Immunol; 1984 Dec; 14(12):1101-5. PubMed ID: 6335095
[TBL] [Abstract][Full Text] [Related]
32. Extensive diversity in the recognition of influenza virus hemagglutinin by murine T helper clones.
Mills KH; Skehel JJ; Thomas DB
J Exp Med; 1986 Jun; 163(6):1477-90. PubMed ID: 2423631
[TBL] [Abstract][Full Text] [Related]
33. Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites.
Nestorowicz A; Tregear GW; Southwell CN; Martyn J; Murray JM; White DO; Jackson DC
Mol Immunol; 1985 Feb; 22(2):145-54. PubMed ID: 2579329
[TBL] [Abstract][Full Text] [Related]
34. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant.
Isobe H; Moran T; Li S; Young A; Nathenson S; Palese P; Bona C
J Exp Med; 1995 Jan; 181(1):203-13. PubMed ID: 7528768
[TBL] [Abstract][Full Text] [Related]
35. Peptide-mediated modulation of T-cell allorecognition.
Eckels DD; Gorski J; Rothbard J; Lamb JR
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8191-5. PubMed ID: 2973061
[TBL] [Abstract][Full Text] [Related]
36. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules.
Jones CM; Lake RA; Lamb JR; Faith A
Eur J Immunol; 1994 May; 24(5):1137-42. PubMed ID: 7514130
[TBL] [Abstract][Full Text] [Related]
37. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.
Krieger JI; Karr RW; Grey HM; Yu WY; O'Sullivan D; Batovsky L; Zheng ZL; Colón SM; Gaeta FC; Sidney J
J Immunol; 1991 Apr; 146(7):2331-40. PubMed ID: 1706393
[TBL] [Abstract][Full Text] [Related]
38. A sensitive method to detect defined peptide among those eluted from murine MHC class II molecules.
Brumeanu TD; Kohanski R; Bona CA; Zaghouani H
J Immunol Methods; 1993 Mar; 160(1):65-71. PubMed ID: 8450239
[TBL] [Abstract][Full Text] [Related]
39. Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.
Ffrench RA; Tang XL; Anders EM; Jackson DC; White DO; Drummer H; Wade JD; Tregear GW; Brown LE
J Virol; 1989 Jul; 63(7):3087-94. PubMed ID: 2786093
[TBL] [Abstract][Full Text] [Related]
40. Characterization of an epitope of the human cytomegalovirus protein IE1 recognized by a CD4+ T cell clone.
Gautier N; Chavant E; Prieur E; Monsarrat B; Mazarguil H; Davrinche C; Gairin JE; Davignon JL
Eur J Immunol; 1996 May; 26(5):1110-7. PubMed ID: 8647175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
